1/2026
vol. 18
List do Redakcji
Considerations on HDR brachytherapy for eyelid carcinoma
- Department of Stomatology, Suzhou Wujiang District Hospital of Traditional Chinese Medicine, Suzhou, PR China
Data publikacji online: 2026/04/24
Plik artykułu
1. Guinot JL, Gutierrez C, Vercher M et al. High-dose-rate brachytherapy for eyelid carcinoma: Implant technique and review. J Contemp Brachytherapy 2025; 17: 415-420.
2.
Frakulli R, Galuppi A, Cammelli S et al. Brachytherapy in non melanoma skin cancer of eyelid: a systematic review. J Contemp Brachytherapy 2015; 7: 497-502.
3.
Laskar SG, Basu T, Chaudhary S et al. Postoperative interstitial brachytherapy in eyelid cancer: long term results and assessment of Cosmesis After Interstitial Brachytherapy scale. J Contemp Brachytherapy 2015; 6: 350-355.
4.
Laskar SG, Kumar A, Sharma P et al. Brachytherapy for eyelid cancers: Re-defining outcomes and esthetics in rare histologies. J Contemp Brachytherapy 2025; 17: 174-182.
5.
Vavassori A, Riva G, Durante S et al. Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma. J Contemp Brachytherapy 2019; 11: 443-448.
6.
Pasha T, Radhakrishna N, Poojar S et al. The irreplaceable art of brachytherapy: A technical note on interstitial high-dose-rate interventional radiotherapy in eyelid tumors. J Contemp Brachytherapy 2025; 17: 191-196.
7.
Fionda B, Placidi E, Rosa E et al. Quality control strategies for head and neck brachytherapy (interventional radiotherapy). J Contemp Brachytherapy 2025; 17: 127-132.
8.
Lliso F, Granero D, Perez-Calatayud J et al. Dosimetric evaluation of internal shielding in a high dose rate skin applicator. J Contemp Brachytherapy 2011; 3: 32-35.
9.
Jungbauer WN Jr, Stearns HD, Diez-Montiel A et al. Diagnosis and treatment of apocrine carcinoma of the head and neck: A systematic review. J Plast Reconstr Aesthet Surg 2026; 115: 190-201.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
